chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt presented to PHN to report redness, tenderness, itching. Pt had wheal that measured 3.4x4.8cm and is raised with some small scattered vesicles noted throughout. Pt denies fever or warmth to area. PHN contacted medical director, who ordered to not give 2nd dose of varicella vaccine to pt. Dr. states pt must be allergic to the vaccine.
Face very sore and facial glands very swollen. ( hard to eat/ chew)    Some lower back pain.
Pain, swellig, rash. Pt used ice on the area, itching, and took Benadryl. Pt given Rx for Betamethasone cream on 4/13/2015.
Numbness/parasthesia of the right scapula; Numbness/parasthesia of the right scapula; This is a spontaneous report from a contactable Physician (patient).  A 31-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 06Jan2021 12:00 (Batch/Lot Number: EK9231), age at vaccination of 31-years-old, as single dose, for covid-19 immunisation.  The patient medical history was not reported. There were no concomitant medications. The patient had not received other vaccine in four weeks. The patient experienced numbness/paraesthesia of the right scapula on 20Jan2021 01:30 PM. No treatment was administered. The patient underwent lab tests and procedures which included sars-cov-2 test negative on an unspecified date. The patient had not recovered from the events.  The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 25Jan2021 12:00 (Batch/Lot Number: EL3247), as single dose, for covid-19 immunisation.  Follow-up attempts completed. No further information expected.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE NEUROPATHY 6/23/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
life threatening event-had to be intubated & put on full life support-in ICU completely recovered in 24hr but has developmental delays, speech delays & sensory integration;
Child presented to the clinic with maculopapular eruption to entire body and fever on 4-16-2018. Rash occured 14 days after vaccinations were administered. As of today 4-19-2018 rash is completely gone.
Patient reported feeling numbness and tingling in her Right arm (opposite of injection site).  She was not feeling any other symptoms (shortness of breath, itching, feverish, dizzy, etc.).  She stated she was comfortable going home and would follow up with provider next week (or seek medical attention if it became severe).
Shingles; Information has been received regarding a case in litigation from a lawyer, an elderly male patient of unknown age, and his spouse. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 11-JUL-2017, at age 68, the patient was administered the zoster vaccine live (ZOSTAVAX) by a pharmacist at a pharmacy (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a physician for the following injury resulting from his zoster vaccine live (ZOSTAVAX) use: Shingles. The patient claimed damages as a result of: injury to themselves, loss of consortium, loss of services, and economic losses. The outcome of the shingles is unknown.  Additional information has been requested.
Normal symptoms the first two days including: slight fever, headache, achy body.   On August 2, 2021 around 2:00 in the afternoon I began to have severe chest pain. I finished work around 5:00PM and my wife and I drove to the Emergency Room. I received a clear EKG. The next day I went to the clinic in my office building. I saw the Physicians Assistant on staff. She ordered blood work and an additional EKG. However, she later reverted to the original EKG as I was able to secure it from the Hospital records. I had an EKG, lung examination and scan, and later an echocardiogram.
Information has been received from a pharmacist referring to a patient of unknown age and gender. On 05-FEB-2015 the patient was vaccinated with a dose of improperly stored ZOSTAVAX (lot#, dosage and route unspecified). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL 9 lot # M044717 for prophylaxis. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to GARDASIL 9.    Additional information has been requested.; Sender's Comments: US-009507513-1709USA000094:
1/4 7pm Vaccication 1/4 8pm started feeling itchy mouth and face 1/4 8:30pm took benadryl 50mg 1/4 11:30 symptoms mostly resolved  1/5 830am sysmtoms returned  1/5 845am benadryl 50mg & went to ER 1/5 ER recommended I take Zyrtek & Pepcid instead of bendryl   as of 1/6 at 11:30am still have a very mild itchy face and tonge
COVID test result= Positive; COVID test result= Positive; blood pressure was 168 over 126; my armed and legs started shaking/felt a vibrating feeling in my arms and joints; dizzy; anxious; Tightness in my chest when breathing; felt irregular heart beats; felt a vibrating feeling in my arms and joints; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 40 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Sep2021 11:30 (Lot number: 30130BA) at the age of 40 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 26Dec2021, outcome "unknown" and all described as "COVID test result= Positive"; BLOOD PRESSURE INCREASED (medically significant) with onset 19Sep2021 13:00, outcome "not recovered", described as "blood pressure was 168 over 126"; TREMOR (non-serious) with onset 19Sep2021 13:00, outcome "not recovered", described as "my armed and legs started shaking/felt a vibrating feeling in my arms and joints"; DIZZINESS (non-serious) with onset 19Sep2021 13:00, outcome "not recovered", described as "dizzy"; ANXIETY (non-serious) with onset 19Sep2021 13:00, outcome "not recovered", described as "anxious"; CHEST DISCOMFORT (non-serious) with onset 19Sep2021 13:00, outcome "not recovered", described as "Tightness in my chest when breathing"; HEART RATE IRREGULAR (non-serious) with onset 19Sep2021 13:00, outcome "not recovered", described as "felt irregular heart beats"; JOINT VIBRATION (non-serious) with onset 19Sep2021 13:00, outcome "not recovered", described as "felt a vibrating feeling in my arms and joints". The events "blood pressure was 168 over 126", "my armed and legs started shaking/felt a vibrating feeling in my arms and joints", "dizzy", "anxious", "tightness in my chest when breathing", "felt irregular heart beats" and "felt a vibrating feeling in my arms and joints" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: blood pressure measurement: (19Sep2021) 168 over 126; heart rate: (19Sep2021) irregular; sars-cov-2 test: (26Dec2021) positive, notes: Nasal Swab. Therapeutic measures were taken as a result of blood pressure increased.  Clinical Course: It was reported that patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No any other medications the patient received within 2 weeks of vaccination. Patient went to the urgent care and was suggested to go to the hospital. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination patient has not been tested for COVID-19.
Site: Pain at Injection Site-Severe, Systemic: Tingling/ nerve pain at injection site-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Developed a large hot red area on arm after receiving the current 2015/2016 influenza vaccination.
This spontaneous report as received from a licensed vocational nurse refers to unspecified patients of unknown ages and genders. ON an unknown date the patients were vaccinated with GARDASIL (route, dose, lot#, expiration date unknown). On an unknown date the patients felt a "burning sensation" while they were receiving GARDASIL. Action taken with therapy and the outcome of the event were unknown. This is one of several reports received from the same source. Additional information has been requested.
09/09/22 presents to EC ED for "fall". PMHx of "CAD, paroxysmal Afib, OA, and osteoporosis"
The right side of my tongue started tingling, and I felt the salivary gland swell. It was sensitive and painful to the touch. Each incident subsides very quickly. My first experience happened when I ate a peppermint patty. The next incident happened when I ate a handful of salted peanuts. My doctor stated it might be a blockage in the gland, but we no longer think that's true. I've had other incidents while eating fruit. The doctor said it could be Oral Allergy Syndrome. She said to continue to hydrate, to suck on a lemon drop to increase salivary function, to use a warm compress, and to massage the duct upwards.
Covid-19 positive after first dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 positive after first dose) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced COVID-19 (Covid-19 positive after first dose). At the time of the report, COVID-19 (Covid-19 positive after first dose) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, SARS-CoV-2 test: positive (Positive) COVID-19 positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported No treatment medication were reported.
56-year-old patient at the time was in the observation area, he approached the paramedic indicating that he has itching in the throat BP 120/80, P 81, SAT 99, clear no lungs obstruction. The person in charge was called who called Doctor ordered BENADRYL 25mg PO Time 5:10 On reassessment. The patient completely improved, and he no longer felt itchy or scratchy in his throat. BP 122/90, R 18, Sat 100, Dxt 108.
Patient reported several pain at injection with swelling.  Reported pain even with clothes touching the arm.    She is taking OTC advil.
high fever for 3 days, rash, stomach pain, weakness, imbalance, unusual fussiness
Severe body aches and headache.  Low back pain.  Temperature between 100.6 and 101.8 today.  Still 101.3 even after Tylenol.
Huge  increase in  Tinnitus in both ears after the vaccine and it has not subsided.
Fatigue, muscle aches, joint pain from 5/30 and still on 5/31.  Took Tylenol Arthritis pain med.
pt recv vax 16OCT97 & 21OCT97 pt devel 2cm crater @ inj site;pt mom described it as a drawing in of the tissue surrounding the inj site but no redness noted;no prior disfigurement recorded;reporter felt pt exp was permanently disfiguring;
Within 3 hours of receiving the vaccination his body broke out into a rash which progressed into hives, welts, a fever of 102 and swollen red eyes. We administered one dose each of infant ADVIL and BENADRYL which mostly relieved his symptoms. The following day he still had a minor rash over body.
About 5PM, crying, fell down, eyes rolled back, not breathing, body jerking, unresponsive, felt warm; thought maybe choking; BP 130/80, no temp;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In or around 10-APR-2010, the patient received ZOSTAVAX for its intended purpose: the prevention of shingles (dose, route, and lot # not provided).  Shortly thereafter, the patient began to experience muscle weakness, hip pain, dizziness, equilibrium issues, and an unsteady gait. In or around June 2012, the patient presented to his physician for the issues and he was diagnosed with Guillain-Barre syndrome. As a direct and proximate result of ZOSTAVAX, the patient's symptoms resulted in physical limitations not present prior to using the product. He also experiences mental and emotional distress due to resulting physical limitations and the seriousness of his condition. As a result of ZOSTAVAX, the patient sustained severe and permanent personal injuries.  Further, as a tragic consequence of the Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment, and injury. The patient sustained serious personal injuries and related losses including, but not limited to, the following: Patient required and will continue to require healthcare and services; patient incurred and will continue to incur medical and related expenses; and patient suffered and will continue to suffer mental anguish, physical pain and suffering, diminished capacity for the enjoyment of life, a diminished quality of life, and other losses and damages. The outcome of Guillain-Barre syndrome was not resolved. Causality assessment was related. The lawyer considered Guillain-Barre syndrome to be disabling. Upon internal review, Guillain-Barre syndrome was considered to be medically significant. Additional information has been requested.
Medication error by administering Moderna vaccine to a 14 year old female patient. Immediately notified Mom and patient who were in the car waiting the mandatory 15 minutes after any given vaccine, called Moderna @ 1420, spoke to representative for Moderna.
Pt c/o hives (L) upper arm, then (R) lower arm, (L) lower arm, face & then "funny feeling in throat," First BENADRYL 25 mg PO then BENADRYL 50 mg IM -> called 911 - > to hospital.
Moderna COVID-19 Vaccine EUA. Raised, red patch just below injection site that is just about 2 inches wide. Resembles an allergic reaction rash and is itchy.  The site was red right after injection but has been raised and gotten larger in the last 2 days.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. In or around 01-OCT-2012, the patient was inoculated with ZOSTAVAX (lot number, expiration, dose and route unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving ZOSTAVAX vaccine (date not reported), the patient suffered Peripheral neuropathy and Chronic inflammatory demyelinating polyneuritis. As a direct and proximate result of ZOSTAVAX, the patient's symptoms have resulted in physical limitations not present prior to using ZOSTAVAX. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence the patient experienced serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. Treatment and outcome of events was unknown. Upon internal review, Peripheral neuropathy and Chronic inflammatory demyelinating polyneuritis were determined to be medically significant events. Peripheral neuropathy and Chronic inflammatory demyelinating polyneuritis were considered disabling. Additional information has been requested.
sharp shooting pain in my right armpit (same side as injection)./my right armpit was swollen; sharp shooting pain in my right armpit (same side as injection)./my right armpit was swollen; This is a spontaneous report from a contactable other HCP. This 25-year-old female other-HCP reported that she received bnt162b2 (BNT162B2, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 04Feb2021 10:00 (Batch/Lot number was not reported) as SINGLE DOSE, dose 1 via an unspecified route of administration, administered in Arm Right on 14Jan2021 16:00 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. Medical history included food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. he patient reported 24 hours after getting the shot, I started having sharp shooting pain in my right armpit (same side as injection). 36 hours later, my right armpit was swollen. It has now been 4 days and my right armpit is still very swollen- have been treating with warm compress. Still have pain but has decreased. The action taken in response to the events for bnt162b2 was not applicable. The outcome of the event swelling was reported as not recovered and for other event is recovering.  Information about lot/batch number has been requested.
PT EXP AN INJECT SITE REACT WHICH INCLUDED SWELLING AND ERYTHEMA WITHIN 24 HRS AFTER IMMUN. PT HAS HAD LOW GRADE FEVER FOR 2 DAYS. BOTH HAVE NOT RESOLVED AS OF 8-17-89.
Pregnant at the time of vaccination. Miscarriage occurred 20 days after vaccination at around 5 weeks along.
Aside from the expected sore right arm, I developed painful welling of underarm glands (right side) which I've NEVER had before even as a child; also developed itching and some redness and swelling at injection site,. These occurred in late afternoon on 3/5/2021 - a day after 2nd Moderna vaccine injection.  I also developed a low fever for part of the same afternoon (3/5) into early eve. I also had some ache in center chest (gone now) which I never had before (angina?).   It is now 3/6/2021 and I still have swollen underarm glands (right arm), right arm soreness at injection site, and some itching there as well. But no fever just now.  I'm VERY CONCERNED the swollen glands will not go away in time for my aortic valve replacement surgery on 3/15/2021.
large red swollen lt deltoid shoulder that pt states does not hurt but it itches;states was bitten by mosquito last noc but had vax on Tuesday PM -DTAP;no other c/o showed swelling to mom @ lunch;ice applied
SUPER SWEATY; FEELS LIKE A HANG OVER; LOW FEVER; MILD NAUSEA; RAGING HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-NOV-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow up to request batch/lot numbers. No concomitant medications were reported. On 13-NOV-2021, the patient experienced super sweaty. On 13-NOV-2021, the patient experienced feels like a hang over. On 13-NOV-2021, the patient experienced low fever. On 13-NOV-2021, the patient experienced mild nausea. On 13-NOV-2021, the patient experienced raging headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the super sweaty, low fever, mild nausea, raging headache and feels like a hang over was not reported. This report was non-serious.
severe headache; fever; chills; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: unknown), via an unspecified route of administration on 23Mar2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if the patient was diagnosed with COVID-19 prior to the vaccination. It was unknown if patient was tested for COVID-19 since the vaccination. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID-19 vaccine. On an unspecified date in Mar2021, the patient had experienced severe headache, fever and chills. It was unknown if the patient received any treatment for the reported events. The clinical outcome of the events headache, fever and chills was resolving at the time of this report. No follow up attempts are possible; Information about lot/batch number cannot be obtained.
swollen left arm near the injection site red circle the 3 inches in diameter not itchy not sore
vaccinated with moderna/rinvoq was not working at all for her rheumatoid arthritis so she quit taking it; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 IMMUNISATION (vaccinated with moderna/rinvoq was not working at all for her rheumatoid arthritis so she quit taking it) in a 57-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On an unknown date, the patient experienced COVID-19 IMMUNISATION (vaccinated with moderna/rinvoq was not working at all for her rheumatoid arthritis so she quit taking it). At the time of the report, COVID-19 IMMUNISATION (vaccinated with moderna/rinvoq was not working at all for her rheumatoid arthritis so she quit taking it) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No concomitant medications were reported. It was unknown if patient was enrolled in a covid-19 vaccine trial. No treatment medications were reported.
Administered vaccine after asking/talking about screening conditions. This was around 2 PM. Patient proceeded to observatoin area where she fainted around 2:05 PM. After talking to patient, she was afraid of needles and passed out due to "hearing" the needle enter her deltoid.
8 days post MMR/DTP/OPV; mom noticed collarline rash 7PM 17SEP91; then noticed sl temp; 18SEP91 mom noticed itchy, raised red rash in AM on rising; Parent presented pt to clinic for exam;